Epygen Biotech Profile
Key Indicators
- Authorised Capital ₹ 19.55 Cr
as on 26-07-2024
- Paid Up Capital ₹ 15.36 Cr
as on 26-07-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 39.56 Cr
as on 26-07-2024
- Revenue 179.47%
(FY 2023)
- Profit 66.14%
(FY 2023)
- Ebitda 135.77%
(FY 2023)
- Net Worth -18.68%
(FY 2023)
- Total Assets -2.46%
(FY 2023)
About Epygen Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 19.55 Cr and a paid-up capital of Rs 15.36 Cr.
The company currently has active open charges totaling ₹39.56 Cr.
Soumitro Deb, Manickam, Ineeyan Ariyaratnam, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233MH2011PTC221254
- Company No.
221254
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Aug 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Rasayani, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Epygen Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ineeyan Ariyaratnam  | Director | 25-Aug-2011 | Current |
Soumitro Deb  | Director | 18-Mar-2020 | Current |
| Manickam | Director | 11-Jul-2016 | Current |
| Debayan Ghosh | Director | 25-Aug-2011 | Current |
Financial Performance and Corporate Structure Insights of Epygen Biotech.
Epygen Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 179.47% increase. The company also saw a substantial improvement in profitability, with a 66.14% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Epygen Biotech?
In 2022, Epygen Biotech had a promoter holding of 74.66% and a public holding of 25.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Beva Silicones Private Limited
Active 15 years 11 monthsManickam and Ineeyan Ariyaratnam are mutual person
Genores Biotech Private Limited
Active 6 years 7 monthsSoumitro Deb, Manickam and 2 more are mutual person
Harris & Menuk Chemicals Private Limited
Active 9 years 8 monthsManickam and Ineeyan Ariyaratnam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Sep 2018 | ₹11.78 Cr | Open |
Others Creation Date: 29 Sep 2016 | ₹27.78 Cr | Open |
How Many Employees Work at Epygen Biotech?
Epygen Biotech has a workforce of 47 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Epygen Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epygen Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
